Logo image of ZTEK

ZENTEK LTD (ZTEK) Stock Fundamental Analysis

NASDAQ:ZTEK - Nasdaq - CA98942X1024 - Common Stock - Currency: USD

1.08  -0.01 (-0.92%)

Fundamental Rating

2

Taking everything into account, ZTEK scores 2 out of 10 in our fundamental rating. ZTEK was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While ZTEK seems to be doing ok healthwise, there are quite some concerns on its profitability. ZTEK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ZTEK has reported negative net income.
In the past year ZTEK has reported a negative cash flow from operations.
ZTEK had negative earnings in each of the past 5 years.
In the past 5 years ZTEK always reported negative operating cash flow.
ZTEK Yearly Net Income VS EBIT VS OCF VS FCFZTEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -50.52%, ZTEK is doing worse than 68.62% of the companies in the same industry.
ZTEK's Return On Equity of -57.83% is in line compared to the rest of the industry. ZTEK outperforms 46.81% of its industry peers.
Industry RankSector Rank
ROA -50.52%
ROE -57.83%
ROIC N/A
ROA(3y)-55.19%
ROA(5y)-53.2%
ROE(3y)-60.58%
ROE(5y)-96.95%
ROIC(3y)N/A
ROIC(5y)N/A
ZTEK Yearly ROA, ROE, ROICZTEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ZTEK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZTEK Yearly Profit, Operating, Gross MarginsZTEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50K -100K -150K

More info and screens

4

2. Health

2.1 Basic Checks

ZTEK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZTEK has been increased compared to 1 year ago.
Compared to 5 years ago, ZTEK has more shares outstanding
The debt/assets ratio for ZTEK is higher compared to a year ago.
ZTEK Yearly Shares OutstandingZTEK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ZTEK Yearly Total Debt VS Total AssetsZTEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

ZTEK has an Altman-Z score of 29.42. This indicates that ZTEK is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 29.42, ZTEK belongs to the best of the industry, outperforming 96.81% of the companies in the same industry.
ZTEK has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
ZTEK has a better Debt to Equity ratio (0.01) than 66.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 29.42
ROIC/WACCN/A
WACC7.77%
ZTEK Yearly LT Debt VS Equity VS FCFZTEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

ZTEK has a Current Ratio of 2.06. This indicates that ZTEK is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ZTEK (2.06) is worse than 64.36% of its industry peers.
ZTEK has a Quick Ratio of 1.63. This is a normal value and indicates that ZTEK is financially healthy and should not expect problems in meeting its short term obligations.
ZTEK has a Quick ratio of 1.63. This is comparable to the rest of the industry: ZTEK outperforms 43.62% of its industry peers.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 1.63
ZTEK Yearly Current Assets VS Current LiabilitesZTEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.53% over the past year.
ZTEK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.16%.
ZTEK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 132.92% yearly.
EPS 1Y (TTM)15.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.03%
Revenue 1Y (TTM)8.16%
Revenue growth 3Y132.92%
Revenue growth 5YN/A
Sales Q2Q%34.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZTEK Yearly Revenue VS EstimatesZTEK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
ZTEK Yearly EPS VS EstimatesZTEK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ZTEK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZTEK Price Earnings VS Forward Price EarningsZTEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZTEK Per share dataZTEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ZTEK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZENTEK LTD

NASDAQ:ZTEK (2/13/2025, 11:08:02 AM)

1.08

-0.01 (-0.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-23 2024-02-23/amc
Earnings (Next)N/A N/A
Inst Owners1%
Inst Owner Change-21.84%
Ins Owners5.79%
Ins Owner ChangeN/A
Market Cap112.36M
Analysts84.44
Price TargetN/A
Short Float %0.27%
Short Ratio5.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4082.55
P/FCF N/A
P/OCF N/A
P/B 8.65
P/tB 8.65
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.52%
ROE -57.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-55.19%
ROA(5y)-53.2%
ROE(3y)-60.58%
ROE(5y)-96.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 28.03%
Cap/Sales 448.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.06
Quick Ratio 1.63
Altman-Z 29.42
F-Score4
WACC7.77%
ROIC/WACCN/A
Cap/Depr(3y)388.68%
Cap/Depr(5y)1742.24%
Cap/Sales(3y)2084.26%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.03%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.16%
Revenue growth 3Y132.92%
Revenue growth 5YN/A
Sales Q2Q%34.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.95%
OCF growth 3YN/A
OCF growth 5YN/A